Compounding Pharmacies Market size to surpass around USD 20.8 billion by 2032 | Fagron, B. Braun, Nephron Pharmaceuticals Corporation, Fresenius Kabi

The global Compounding Pharmacies Market was valued at 11.2 billion in 2022 and it is anticipated to grow up to USD 20.8 billion by 2032, at a CAGR of 6.4% during the forecast period.

An Compounding Pharmacies is a type of financial institution that provides loans and other forms of financing to individuals and businesses. These platforms typically use online platforms and peer-to-peer lending models to connect borrowers with lenders. Alternative lending platforms typically have lower borrowing costs and faster funding timelines than traditional banks.

Request free sample copy of this research study: https://www.globalinsightservices.com/request-sample/GIS10526

Market Trends and Drivers

Shortage of different drugs including lifesaving drugs and other cancer medicines will boost the demand from compounding pharmacies. Some of the major factors responsible for shortages are quality and manufacturing issues. Moreover, disruption of supply chains due to the COVID-19 pandemic has also resulted in delays in the process. The postponement in raw materials supply leads to a delay in manufacturing process. This ultimately affected the supply of medication leading to its shortage. Limited capability of raw material suppliers along with long lead times and complexity of manufacturing process increases drug shortages. Drug shortages can lead to delayed or cancelled patient care and can adversely affect healthcare system revenues. Additionally, shortage of lifesaving drugs along with the unavailability of alternatives could lead to death of the patient. Therefore, capability of compounding pharmacies to critically fill the crucial gap will fuel the market expansion.

Market Restraints and Challenges

The key restraints and challenges in the Compounding Pharmacies market include the stringent regulations, the need for a large amount of capital, and the lack of awareness among small businesses. The stringent regulations are the primary restraint for the growth of the Compounding Pharmacies market.

Major Players in the Global Compounding Pharmacies Market

Market players are focusing on strategic collaborations to enhance their product offerings. Some prominent participants in the global Compounding Pharmacies market include Fagron, B. Braun, Nephron Pharmaceuticals Corporation, Fresenius Kabi, Athenex Pharma Solutions (Athenex Inc.), Dougherty’s Pharmacy, Inc., Clinigen Group PLC, Pencol Compounding Pharmacy, Lorraine’s Pharmacy, McGuff Company Inc. (McGuff Compounding Pharmacy Services), Institutional Pharmacy Solutions, Rx3 Compounding Pharmacy, Wedgewood Village Pharmacy, Inc., and Triangle Compounding Pharmacies, among others.

Speak to Analyst for more details:  https://www.globalinsightservices.com/request-customization/GIS10526

COVID-19 Impact:

COVID-19 significantly impacted the compounding pharmacy market as many people with chronic conditions faced difficulties obtaining their medicines due to closed medical offices and imposed government lockdown in several countries. Several compounding pharmacies started an easy and secure way for patients to transfer their compound prescriptions online and receive medicine at their doorstep. Also, the demand for the compounding pharmacy is expected to drive the growth of the market during the pandemic period. As per the article ‘ Drug Compounding Helped Address Drug Gaps During COVID’ published in July 2021 to help mitigate COVID drug shortages, in April 2020, the Food and Drug Administration’s temporary guidelines stated that compound COVID-19-related drugs without a specific prescription. Such technological up-gradation in compounding pharmacy practices and the gap in demand & supply during a pandemic are key factors driving the market’s growth.

Global Compounding Pharmacies Market Segmentation

By Product

  • Oral
  • Topical
  • Rectal
  • Parenteral
  • Opthalmic
  • Nasel
  • Otic

By Therapeutic Area

  • Nutritional Supplements
  • Hormone Replacement
  • Dermatology
  • Pain Management
  • Specialty Drugs
  • Others

By Application

  • Pediatric
  • Geriatric
  • Veterinary
  • Adult

By Compounding Type

  • Pharmaceutical Dosage Alteration [PDA]
  • Currently Unavailable Pharmaceutical Manufacturing [CUPM]
  • Pharmaceutical Ingredient Alteration [PIA]
  • Others

By Distribution Channel

  • Compounding Pharmacy
  • Hospital Pharmacy
  • Others

Purchase your copy now: https://www.globalinsightservices.com/checkout/single_user/GIS10526

With Global Insight Services, you receive:

  • 10-year forecast to help you make strategic decisions
  • In-depth segmentation which can be customized as per your requirements
  • Free consultation with lead analyst of the report
  • Excel data pack included with all report purchases
  • Robust and transparent research methodology

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: [email protected]
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/